Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients
- 1 September 2016
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 298, 51-57
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81070963)
- Natural Science Foundation of Shandong Province (ZR2010HM019)
This publication has 26 references indexed in Scilit:
- Myasthenia gravis: subgroup classification and therapeutic strategiesThe Lancet Neurology, 2015
- Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis DevelopmentPLOS ONE, 2014
- Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian populationJournal of the Neurological Sciences, 2014
- Genetic basis of myasthenia gravis – A comprehensive reviewJournal of Autoimmunity, 2014
- The high frequency and clinical feature of seronegative myasthenia gravis in Southern ChinaNeurological Sciences, 2012
- Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysisMolecular Biology Reports, 2012
- Genome‐wide association study validation identifies novel loci for atherosclerotic cardiovascular diseaseJournal of Thrombosis and Haemostasis, 2012
- Epidemiology of Thymoma and Associated MalignanciesJournal of Thoracic Oncology, 2010
- A sensitive non-isotopic assay for acetylcholine receptor autoantibodiesClinica Chimica Acta, 2006
- Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodiesNeurology, 2001